Published in Pediatr Pulmonol on April 01, 2005
Management of severe asthma in children. Lancet (2010) 1.60
Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines. J Allergy Clin Immunol (2012) 1.45
The molecular phenotype of severe asthma in children. J Allergy Clin Immunol (2010) 1.36
Partitioned exhaled nitric oxide to non-invasively assess asthma. Respir Physiol Neurobiol (2008) 0.93
Procedures for collection of induced sputum specimens from children. Clin Infect Dis (2012) 0.93
Longitudinal relationship between sputum eosinophils and exhaled nitric oxide in children with asthma. Am J Respir Crit Care Med (2013) 0.85
Severe asthma in children. J Allergy Clin Immunol Pract (2014) 0.80
Researching asthma across the ages: insights from the National Heart, Lung, and Blood Institute's Asthma Network. J Allergy Clin Immunol (2014) 0.80
Phenotypes of severe asthma among children and adolescents in Brazil: a prospective study. BMC Pulm Med (2015) 0.75
Clinical characteristics of children and adolescents with severe therapy-resistant asthma in Brazil. J Bras Pneumol (2015) 0.75
Biomarkers for the Phenotyping and Monitoring of Asthma in Children. Curr Treat Options Allergy (2016) 0.75
Safety of Induced Sputum Collection in Children Hospitalized With Severe or Very Severe Pneumonia. Clin Infect Dis (2017) 0.75
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J (2013) 8.39
An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med (2007) 4.10
A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Am J Respir Crit Care Med (2007) 3.83
Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol (2010) 3.12
Relationship between serum vitamin D, disease severity, and airway remodeling in children with asthma. Am J Respir Crit Care Med (2011) 3.00
The Th17 pathway in cystic fibrosis lung disease. Am J Respir Crit Care Med (2011) 2.87
Retracted The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma. Am J Respir Crit Care Med (2006) 2.72
Longitudinal evaluation of airway function 21 years after preterm birth. Am J Respir Crit Care Med (2008) 2.35
Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med (2005) 2.26
Prospects for new drugs for chronic obstructive pulmonary disease. Lancet (2004) 2.17
Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 2.13
Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med (2007) 2.09
Mutations in radial spoke head protein genes RSPH9 and RSPH4A cause primary ciliary dyskinesia with central-microtubular-pair abnormalities. Am J Hum Genet (2009) 2.07
Quality, size, and composition of pediatric endobronchial biopsies in cystic fibrosis. Chest (2007) 2.05
Rapid diagnosis of primary ciliary dyskinesia: cell culture and soft computing analysis. Eur Respir J (2012) 2.04
Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening. Thorax (2012) 2.01
Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med (2003) 1.94
Practice imperfect--treatment for wheezing in preschoolers. N Engl J Med (2009) 1.90
Prevalence of asthma among Qatari schoolchildren: International Study of Asthma and Allergies in Childhood, Qatar. Pediatr Pulmonol (2006) 1.88
Of flies, mice and men: a systematic approach to understanding the early life origins of chronic lung disease. Thorax (2012) 1.88
Cystic fibrosis. BMJ (2007) 1.82
Lung function from infancy to the preschool years after clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med (2008) 1.79
Use of sputum eosinophil counts to guide management in children with severe asthma. Thorax (2011) 1.73
Lung clearance index in primary ciliary dyskinesia and bronchiectasis. Am J Respir Crit Care Med (2014) 1.73
Airway remodelling and its relationship to inflammation in cystic fibrosis. Thorax (2010) 1.67
Voriconazole therapy in children with cystic fibrosis. J Cyst Fibros (2005) 1.67
Sputum inflammatory phenotypes are not stable in children with asthma. Thorax (2012) 1.65
Repeatability of sodium and chloride in exhaled breath condensates. Pediatr Pulmonol (2004) 1.63
The C-159T polymorphism in the CD14 promoter is associated with serum total IgE concentration in atopic Chinese children. Pediatr Allergy Immunol (2003) 1.62
Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med (2005) 1.56
Genotyping in primary ciliary dyskinesia: ready for prime time, or a fringe benefit? Thorax (2012) 1.52
Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases. Nat Rev Drug Discov (2007) 1.52
Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis. Am J Respir Crit Care Med (2004) 1.49
Symptom-pattern phenotype and pulmonary function in preschool wheezers. J Allergy Clin Immunol (2010) 1.48
Waist circumference and waist-to-height ratio of Hong Kong Chinese children. BMC Public Health (2008) 1.48
Oscillometric 24-h ambulatory blood pressure reference values in Hong Kong Chinese children and adolescents. J Hypertens (2014) 1.48
Body fat measured by bioelectrical impedance in Hong Kong Chinese children. Hong Kong Med J (2009) 1.47
An update on paediatric asthma. Eur Respir Rev (2012) 1.46
Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines. J Allergy Clin Immunol (2012) 1.45
Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI). Thorax (2010) 1.45
Does lidocaine gel alleviate the pain of bladder catheterization in young children? A randomized, controlled trial. Pediatrics (2005) 1.45
Corticosteroids in respiratory diseases in children. Am J Respir Crit Care Med (2012) 1.44
Cystic fibrosis: keeping it in the family. Pediatr Pulmonol (2002) 1.41
Basic science research vs. clinical research in cystic fibrosis: Has the pendulum swung too far? Pediatr Pulmonol (2003) 1.39
Journal policy on research funded by the tobacco industry. Thorax (2013) 1.38
Management of primary ciliary dyskinesia in European children: recommendations and clinical practice. Eur Respir J (2012) 1.38
Airway remodelling in children with cystic fibrosis. Thorax (2007) 1.38
Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume tests. Thorax (2006) 1.37
Progression of lung disease in primary ciliary dyskinesia: is spirometry less accurate than CT? Pediatr Pulmonol (2011) 1.34
Diagnosing primary ciliary dyskinesia. Thorax (2007) 1.31
Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med (2002) 1.27
The role of 1α,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL-10+ CD4+ T cells. Eur J Immunol (2012) 1.27
Increased airway smooth muscle mass in children with asthma, cystic fibrosis, and non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med (2008) 1.27
Lung clearance index at 4 years predicts subsequent lung function in children with cystic fibrosis. Am J Respir Crit Care Med (2010) 1.26
Airway eosinophilia in children with severe asthma: predictive values of noninvasive tests. Am J Respir Crit Care Med (2006) 1.26
Thyroid dysfunction in patients with type 1 diabetes: a longitudinal study. Diabetes Care (2003) 1.25
Immunisation in the current management of cystic fibrosis patients. J Cyst Fibros (2005) 1.25
Comparative study of nasopharyngeal aspirate and nasal swab specimens for diagnosis of acute viral respiratory infection. J Clin Microbiol (2008) 1.25
The evolution of airway function in early childhood following clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med (2004) 1.20
Is there still a gender gap in cystic fibrosis? Chest (2005) 1.16
Neonatal cytokine profile in the airway mucosal lining fluid is skewed by maternal atopy. Am J Respir Crit Care Med (2011) 1.14
IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma. J Allergy Clin Immunol (2013) 1.14
Associations of sleep duration with obesity and serum lipid profile in children and adolescents. Sleep Med (2011) 1.13
Non-specific interstitial pneumonia in cigarette smokers: a CT study. Eur Radiol (2009) 1.13
Objective monitoring of cough in children with cystic fibrosis. Pediatr Pulmonol (2002) 1.11
Correlation between cough frequency and airway inflammation in children with primary ciliary dyskinesia. Pediatr Pulmonol (2005) 1.11
A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res (2007) 1.10
Inflammatory cytokine profile in children with severe acute respiratory syndrome. Pediatrics (2004) 1.10
Long-term macrolide treatment for chronic respiratory disease. Eur Respir J (2012) 1.07
NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis. Thorax (2011) 1.07
Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial. J Nucl Cardiol (2008) 1.07
Flow-to-volume "dysanapsis" in cystic fibrosis. Am J Respir Crit Care Med (2013) 1.07
Pathophysiological features of asthma develop in parallel in house dust mite-exposed neonatal mice. Am J Respir Cell Mol Biol (2009) 1.06
Measurement of bronchial and alveolar nitric oxide production in normal children and children with asthma. Am J Respir Crit Care Med (2006) 1.06
Quality control for spirometry in preschool children with and without lung disease. Am J Respir Crit Care Med (2004) 1.05
A novel method for assessing unchallenged levels of mediators in nasal epithelial lining fluid. J Allergy Clin Immunol (2010) 1.05
Lung clearance index and high-resolution computed tomography scores in primary ciliary dyskinesia. Am J Respir Crit Care Med (2013) 1.04
Infants born to mothers with severe acute respiratory syndrome. Pediatrics (2003) 1.04
Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes. J Immunol Methods (2012) 1.04
Safety and efficacy of Sildenafil therapy in children with pulmonary hypertension. Int J Cardiol (2005) 1.03
Vitamin D and asthma in children. Paediatr Respir Rev (2011) 1.03
Long-acting beta 2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified? Curr Opin Pharmacol (2003) 1.03
Relationship of sleep quantity and quality with 24-hour urinary catecholamines and salivary awakening cortisol in healthy middle-aged adults. Sleep (2011) 1.03
Classification and pharmacological treatment of preschool wheezing: changes since 2008. Eur Respir J (2014) 1.03
Diffuse lung disease in infancy and childhood: expanding the chILD classification. Histopathology (2013) 1.02
The challenge of asthma in adolescence. Pediatr Pulmonol (2007) 1.01
Breath condensate pH in children with cystic fibrosis and asthma: a new noninvasive marker of airway inflammation? Chest (2004) 1.01
Increased interleukin-4 and decreased interferon-gamma in exhaled breath condensate of children with asthma. Am J Respir Crit Care Med (2002) 1.00
Bronchoscopy following diagnosis with cystic fibrosis. Arch Dis Child (2006) 0.99
Serial analysis of the plasma concentration of SARS coronavirus RNA in pediatric patients with severe acute respiratory syndrome. Clin Chem (2003) 0.99
A novel flow cytometric assay of human whole blood neutrophil and monocyte CD11b levels: upregulation by chemokines is related to receptor expression, comparison with neutrophil shape change, and effects of a chemokine receptor (CXCR2) antagonist. Pulm Pharmacol Ther (2006) 0.99
Biomarkers for cystic fibrosis lung disease: application of SELDI-TOF mass spectrometry to BAL fluid. J Cyst Fibros (2008) 0.98